Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-019150
Filing Date
2019-07-03
Accepted
2019-07-03 16:17:11
Documents
1
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3153
  Complete submission text file 0000899243-19-019150.txt   4606
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94101
Business Address
Sinha Uma (Reporting) CIK: 0001742587 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 19942085

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations